Anondita Medicare IPO Logo

Anondita Medicare IPO

Live Updates, GMP, Subscription Data, and Financial Details

IPO Overview

Listed
Dates Aug 22 to Aug 26 2025
Price Band ₹145
Current GMP ₹275.5(+90%)
Subscription 300.89 times

IPO Details

IPO Date
August 22, 2025 to August 26, 2025
Listing Date
September 1, 2025
Face Value
₹10 per share
Issue Price
₹145 per share
Lot Size
1,000 Shares
Sale Type
Fresh Capital
Total Issue Size
47,93,000 shares (aggregating up to ₹69.50 Cr)
Reserved for Market Maker
2,70,000 shares (aggregating up to ₹3.92 Cr)Mansi Share & Stock Broking Pvt.Ltd.
Net Offered to Public
45,23,000 shares (aggregating up to ₹65.58 Cr)
Issue Type
Bookbuilding IPO
Listing At
NSE SME
Share Holding Pre Issue
1,32,93,618 shares
Share Holding Post Issue
1,80,86,618 shares

IPO Subscription Details

Anchor Investors
1
Market Maker
1
QIB (Ex Anchor)
153.03
Non-Institutional Buyers***
531.82
bNII (bids above ₹10L)
641.02
sNII (bids below ₹10L)
313.43
Individual Investors (IND category bidding for 2 Lots)
286.20
Total **
300.89

Day Wise Sub

DayDay 1 Aug 22, 2025
QIB (Ex Anchor)0.11
NII*1.93
NII (> ₹10L)1.43
NII (< ₹10L)2.94
Individual Investors5.99
Total3.44
DayDay 2 Aug 25, 2025
QIB (Ex Anchor)2.17
NII*56.77
NII (> ₹10L)64.22
NII (< ₹10L)41.87
Individual Investors56.63
Total41.11
DayDay 3 Aug 26, 2025
QIB (Ex Anchor)153.03
NII*531.82
NII (> ₹10L)641.02
NII (< ₹10L)313.43
Individual Investors286.20
Total300.89

Day Wise GMP

Date01-09-2025
Price145.00
GMP89(61.38%)
Estimate List Price234
Date31-08-2025
Price145.00
GMP89(61.38%)
Estimate List Price234
Date30-08-2025
Price145.00
GMP85(58.62%)
Estimate List Price230
Date29-08-2025
Price145.00
GMP80(55.17%)
Estimate List Price225
Date28-08-2025
Price145.00
GMP92(63.45%)
Estimate List Price237
Date27-08-2025
Price145.00
GMP84(57.93%)
Estimate List Price229
Date26-08-2025
Price145.00
GMP80(55.17%)
Estimate List Price225
Date25-08-2025
Price145.00
GMP73(50.34%)
Estimate List Price218
Date24-08-2025
Price145.00
GMP65(44.83%)
Estimate List Price210
Date23-08-2025
Price145.00
GMP65(44.83%)
Estimate List Price210
Date22-08-2025
Price145.00
GMP65(44.83%)
Estimate List Price210
Date21-08-2025
Price145.00
GMP65(44.83%)
Estimate List Price210
Date20-08-2025
Price145.00
GMP28(19.31%)
Estimate List Price173
Date19-08-2025
Price145.00
GMP0(0.00%)
Estimate List Price145

IPO Important Dates

IPO Open Date
Fri, Aug 22, 2025
IPO Close Date
Tue, Aug 26, 2025
Tentative Allotment
Thu, Aug 28, 2025
Initiation of Refunds
Fri, Aug 29, 2025
Credit of Shares to Demat
Fri, Aug 29, 2025
Tentative Listing Date
Mon, Sep 1, 2025
Cut-off time for UPI mandate confirmation
5 PM on August 26, 2025

IPO Lot Size

ApplicationIndividual investors (Retail) (Min)
Lots2
Shares2,000
Amount₹2,90,000
ApplicationIndividual investors (Retail) (Max)
Lots2
Shares2,000
Amount₹2,90,000
ApplicationS-HNI (Min)
Lots3
Shares3,000
Amount₹4,35,000
ApplicationS-HNI (Max)
Lots6
Shares6,000
Amount₹8,70,000
ApplicationB-HNI (Min)
Lots7
Shares7,000
Amount₹10,15,000

Financial Information

Period EndedPeriod Ended
31 Mar 202531 Mar 2025
31 Mar 202431 Mar 2024
31 Mar 202331 Mar 2023
Period EndedAssets
31 Mar 202578.27
31 Mar 202442.92
31 Mar 202337.80
Period EndedTotal Income
31 Mar 202577.13
31 Mar 202446.56
31 Mar 202336.14
Period EndedProfit After Tax
31 Mar 202516.42
31 Mar 20243.84
31 Mar 20230.35
Period EndedEBITDA
31 Mar 202525.65
31 Mar 20249.09
31 Mar 20233.58
Period EndedNet Worth
31 Mar 202537.87
31 Mar 202410.59
31 Mar 20238.69
Period EndedReserves and Surplus
31 Mar 202524.58
31 Mar 202410.39
31 Mar 20236.55
Period EndedTotal Borrowing
31 Mar 202527.39
31 Mar 202424.01
31 Mar 202322.66

Peers Comparison

Company NameAnondita Medicare Limited
EPS (Basic)9.60
EPS (Diluted)9.60
NAV (per share) (Rs)21.32
P/E (x)
RoNW (%)38.10
P/BV Ratio
Company NameCupid Ltd.
EPS (Basic)1.52
EPS (Diluted)1.52
NAV (per share) (Rs)12.75
P/E (x)110.38
RoNW (%)11.96
P/BV Ratio13.92

IPO Reservation

Market Maker Shares Offered
2,70,000 (5.63%)
QIB Shares Offered
22,56,000 (47.07%)
− Anchor Investor Shares Offered
13,50,000 (28.17%)
− QIB (Ex. Anchor) Shares Offered
9,06,000 (18.90%)
NII (HNI) Shares Offered
6,81,000 (14.21%)
− bNII > ₹10L
4,56,000 (9.51%)
− sNII < ₹10L
2,25,000 (4.69%)
Retail Shares Offered
15,86,000 (33.09%)
Total Shares Offered
47,93,000 (100.00%)

Information about company

Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.” The company produces 562 million condoms annually. The company has a manufacturing facility situated in Noida, Uttar Pradesh. Anondita Medicare exports its products to several international markets, including Southeast Asia, Africa, and the Middle East. The company collaborates with global health organizations, NGOs, and governments to support family planning and public health initiatives. Anondita Medicare has a robust distribution network that ensures the timely delivery of its products to various markets. The company collaborates with wholesalers, retailers, and e-commerce platforms to make its products widely accessible. It also has strong ties with government health programs and institutions, playing a key role in supplying essential medical products for public health initiatives. As on July 31, 2025, the Company had 280 employees. Competitive Strength: Experienced and significant condom manufacturer in India. Well-recognized in North India Offers a diverse range of products.

Objectives of IPO

The Company Anondita Medicare IPO proposes to utilise the Net Proceeds from the Issue towards the following objects: S.No. Objects of the Issue Expected Amount (₹ in crores) 1 Funding capital expenditure requirements for the purchase of equipment/machineries 6.00 2 Funding the Working Capital requirement 35.00 3 Unidentified Acquisition and General Corporate Purposes 20.16

Disclaimer

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App